Photo by john_cameron from unsplash
DAB2IP is lost in early-stage tumors, which amplifies RAS signaling, triggers inflammatory mediators, and recruits macrophages in KRAS-mutant colon cancers. Click to show full abstract
DAB2IP is lost in early-stage tumors, which amplifies RAS signaling, triggers inflammatory mediators, and recruits macrophages in KRAS-mutant colon cancers.
Keywords:
kras mutant;
bifunctional tumor;
dab2ip bifunctional;
mutant colon;
cancer
Journal Title: Cancer Research
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer Research
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!